Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0001209191-19-005130

Options or other derivatives

  • Head of Development & CMO acquired 140,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

GUALBERTO ANTONIO · Head of Development & CMO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-01-22 Grant or award : show line 1 in the form Option to purchase common stock +140,000 $15.47 2029-01-21 140,000 140,000 D
Loading xslF345X03/doc4.xml…